Journal of Cancer Research and Therapeutics Close
 

Figure 3: (a) Immunostains with EMA showing positivity in salivary duct carcinoma and also in few mononuclear cells. (DAB; × 100) (b) Immunostains with pan CK showing positivity only in the salivary duct carcinoma component (DAB; × 100) (c) Immunostains with CEA showing positivity only in the salivary duct carcinoma component (DAB; × 100) (d) Immunostains with CD68 showing positivity in the osteoclastic giant cells and in few mononuclear cells only. (DAB; × 100)

Figure 3: (a) Immunostains with EMA showing positivity in salivary duct carcinoma and also in few mononuclear cells. (DAB; × 100) (b) Immunostains with pan CK showing positivity only in the salivary duct carcinoma component (DAB; × 100) (c) Immunostains with CEA showing positivity only in the salivary duct carcinoma component (DAB; × 100) (d) Immunostains with CD68 showing positivity in the osteoclastic giant cells and in few mononuclear cells only. (DAB; × 100)